B+
Bull case
20%
Probability
Target price
$31.50
+4.1% vs current
AMN
AMN Healthcare ServicesANYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$22.50
-25.6% vs current
B-
Bear case
30%
Probability
Target price
$16.50
-45.5% vs current
AI sentiment snapshot
Latest data as of 2026-05-21
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+22.7
Score
AI commentary
Primary-source evidence is strong and the May 7, 2026 print was clearly better than expected, but the market still has to digest a softer Q2 outlook and the fact that much of Q1 strength came from labor-disruption revenue and timing-related deposits. Recent coverage points to a positive but not euphoric reaction, and analyst revisions appear limited so far; that keeps this in monitoring mode rather than a high-conviction bullish call.
RankAlpha Sentiment Codex - 2026-05-21
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-07catalystQ1 beat and Q2 guide reset the near-term setupHigh impact
AMN reported Q1 2026 revenue of $1.378 billion and adjusted diluted EPS of $2.10, both above guidance, and set Q2 revenue guidance of $620-$635 million; management also said travel nurse volume and revenue grew year over year for the first time since 2022 [#8-K-2026-05-07].
2026-06-30eventLabor-disruption revenue should normalize after a timing-heavy quarterMedium impact
Labor disruption events contributed $722 million of Q1 revenue and $367 million of quarter-end client deposits, so part of the quarter's strength was timing-driven and likely to unwind over the next few months [#8-K-2026-05-07].
2026-12-31catalystDurable rerating still depends on competitive share and mix gainsHigh impact
The 2025 10-K describes a highly competitive healthcare staffing and workforce-solutions market with direct rivals including Amergis, Aya Healthcare, CHG Healthcare Services, Cross Country Healthcare, HealthTrust Workforce Solutions, Ingenovis Health, Jackson Healthcare, LanguageLine Solutions, and Medical Solutions; that suggests the stock needs sustained share and mix gains rather than one-quarter event revenue to justify a higher multiple [#10-K-2026-02-20].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-21 • Updated nightlySource: Internal modelMethodology